Anne Marit de Groot

Johnson & Johnson (Israel) — Israel

Medicine · Health Sciences

19h-index2.9kcitations33works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(17), COVID-19 Clinical Research Studies(13), Immunotherapy and Immune Responses(4), RNA Interference and Gene Delivery(4), Vaccine Coverage and Hesitancy(4)

Publications29 total

Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy
Human Vaccines & Immunotherapeutics·2025· 1 citedOpen Access
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial
Human Vaccines & Immunotherapeutics·2025· 2 citedOpen Access
Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16–17 Years of Age
Journal of the Pediatric Infectious Diseases Society·2024Open Access
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
PLoS ONE·2022· 31 citedOpen Access
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials
Vaccine·2022· 32 citedOpen Access
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters
npj Vaccines·2022· 2 citedOpen Access
LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials
Open Forum Infectious Diseases·2021Open Access
Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting
2021· 23 citedOpen Access
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
New England Journal of Medicine·2021· 252 citedOpen Access
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2021Open Access
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
2021· 20 citedOpen Access
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Nature·2021· 342 citedOpen Access
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
JAMA·2021· 313 citedOpen Access
Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responses
Journal of Extracellular Vesicles·2021· 92 citedOpen Access
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
New England Journal of Medicine·2021· 1.2k citedOpen Access
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial
2020· 141 citedOpen Access
Human milk extracellular vesicles target nodes in interconnected signalling pathways that enhance oral epithelial barrier function and dampen immune responses
2020· 7 citedOpen Access
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
Molecular Therapy — Nucleic Acids·2018· 39 citedOpen Access
Lipid-polymer hybrid nanoparticles (LPNs) for efficient pulmonary delivery of nucleic acids: Lessons learnt from quality-by-design based optimization, immunogenicity studies, in vitro release experiments, in vivo biodistribution and efficacy studies
2018
Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
Frontiers in Immunology·2017· 29 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Mathieu Le Gars(14), Frank Struyf(13), Macaya Douoguih(13), Jerald Sadoff(12), Hanneke Schuitemaker(12), Dirk Heerwegh(11), Johan Van Hoof(10), Alice J.A.M. Sijts(9), Kathryn E. Stephenson(8), Dan H. Barouch(8), Carla Truyers(7), Gert C. Scheper(7), Jenny Hendriks(7), Georgi Shukarev(6), Jingyou Yu(6), Abishek Chandrashekar(6), Jinyan Liu(5), Katherine McMahan(5), Aiquan Chang(5), Femke Broere(5)